DSCR1/RCAN1 regulates vesicle exocytosis and fusion pore kinetics: Implications for Down syndrome and Alzheimer's disease

Human Molecular Genetics

Volumn 17, Issue 7, 2008, Pages 1020-1030

  Keating, Damien J ^a,b   Dubach, Daphne ^c   Zanin, Mark P ^a   Yu, Yong ^c   Martin, Katherine ^c   Zhao, Yu Feng ^b   Chen, Chen ^b   Porta, Sílvia ^d,e   Arbonés, Maria L ^e   Mittaz, Laureane ^c   Pritchard, Melanie A ^c  

^a FLINDERS UNIVERSITY   (Australia)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e CENTRE FOR GENOMIC REGULATION CRG   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CALCIUM; CARBON FIBER; CATECHOLAMINE; DOWN SYNDROME CANDIDATE REGION PROTEIN 1; NEUROTRANSMITTER; REGULATOR OF CALCINEURIN ACTIVITY 1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMPEROMETRY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CATECHOLAMINE RELEASE; CHROMAFFIN CELL; CONTROLLED STUDY; DOWN SYNDROME; EXOCYTOSIS; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; MOUSE; MOUSE MUTANT; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SYNAPSE VESICLE;

ALZHEIMER DISEASE; ANIMALS; CALCINEURIN; CALCIUM; CHROMAFFIN CELLS; CYTOPLASMIC VESICLES; DOWN SYNDROME; EXOCYTOSIS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; MALE; MEMBRANE FUSION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCLE PROTEINS;

MUS;

EID: 41149154002     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm374     Document Type: Article

References (31)

1. Lai, F., Kammann, E., Rebeck, G.W., Anderson, A., Chen, Y. and Nixon, R.A. (1999) APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome. Neurology, 53, 331-336.
2. Bucci, C., Parton, R.G., Mather, I.H., Stunnenberg, H., Simons, K., Hoflack, B. and Zerial, M. (1992) The small GTPasc rab5 functions as a regulatory factor in the early endocytic pathway. Cell, 70, 715-728.
3. Cataldo, A.M., Peterhoff, C.M., Troncoso, J.C., Gomez-Isla, T., Hyman, B.T. and Nixon, R.A. (2000) Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: Differential effects of APOE genotype and presenilin mutations. Am. J. Pathol., 157, 277-286.
4. Cataldo, A.M., Petanceska, S., Peterhoff, C.M., Terio, N.B., Epstein, C.J., Villar, A., Carlson, E.J., Staufenbiel, M. and Nixon, R.A. (2003) App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome. J. Neurosci. 23, 6788-6792.
5. Greber, S., Lubec, G., Cairns, N. and Fountoulakis, M. (1999) Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease. Electrophoresis, 20 928-934.
6. Arai, Y., Ijuin, T., Takenawa, T., Becker, L,E. and Takashima, S. (2002) Excessive expression of synaptojanin in brains with Down syndrome. Brain Dev., 24, 67-72.
7. Tan, T.C., Valova, V.A., Malladi, C.S., Graham, M.E., Berven, L.A., Jupp, O.J., Hansra, G., McClure, S.J., Sarcevic, B., Boadle, R.A. et al. (2003) Cdk5 is essential for synaptic vesicle endocytosis. Nat. Cell Biol., 5, 701-710.
8. Lee, M.S., Kwon, Y.T., Li, M., Peng, J., Friedlander, R.M. and Tsai, L.H. (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature, 405, 360-364.
9. Patrick, G.N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P. and Tsai, L.H. (1999) Conversion of p3 5 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature, 402, 615-622.
10. Fuentes, J.J., Pritchard, M.A., Planas, A.M., Bosch, A., Ferrer, I. and Estivill, X. (1995) A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart. Hum. Mol. Genet., 4, 1935-1944.
11. Ermak, G., Morgan, T.E. and Davies, K.J. (2001) Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer's disease. J. Biol. Chem., 276, 38787-38794.
12. Fuentes, J.J., Genesca, L., Kingsbury, T.J., Cunningham, K.W., Perez-Riba, M., Estivill, X. and de la Luna, S. (2000) DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum. Mol. Genet., 9, 1681-1690.
13. Ma, H., Mong, H., Liu, T., Zhang, L., Godzik, A. and Zhang, Z. (2004) Aggregate formation and synaptic abnormality induced by DSCR1. J. Neurochem., 88, 1485-1496.
14. Chang, K.T., Shi, Y.J. and Min, K.T. (2003) The Drosophila homolog of Down's syndrome critical region 1 gene regulates learning: Implications for mental retardation. Proc. Natl. Acad. Sci. USA, 100, 15794-15799.
15. Chang, K.T. and Min, K.T. (2005) Drosophila melanogaster homolog of Down syndrome critical region 1 is critical for mitochondrial function. Nat. Neurosci., 8, 1577-1585.
16. Fuentes, J.J., Pritchard, M.A. and Estivill, X. (1997) Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Genomics, 44, 358-361.
17. Chow, R.H., von Ruden, L. and Neher, E. (1992) Delay in vesicle fusion revealed by electrochemical monitoring of single secretory events in adrenal chromaffin cells. Nature, 356, 60-63.
18. Alvarez de Toledo, G., Fernandez-Chacon, R. and Fernandez, J.M. (1993) Release of secretory products during transient vesicle fusion. Nature 363, 554-558.
19. Borges, R., Travis, E.R., Hochstetler, S.E. and Wightman, R.M. (1997) Effects of external osmotic pressure on vesicular secretion from bovine adrenal medullary cells. J. Biol. Chem., 272, 8325-8331.
20. Gil, A., Viniegra, S. and Gutierrez, L.M. (2001) Temperature and PMA affect different phases of exocytosis in bovine chromaffin cells. Eur. J. Neurosci., 13, 1380-1386.
21. Colliver, T.L., Pyott, S.J., Achalabun, M. and Ewing, A.G. (2000) VMAT-Mediated changes in quantal size and vesicular volume. J. Neurosci., 20, 5276-5282.
22. Pothos, E.N., Mosharov, E., Liu, K.P., Setlik, W., Haburcak, M., Baldini, G., Gershon, M.D., Tamir, H. and Sulzer, D. (2002) Stimulation-dependent regulation of the pH, volume and quantal size of bovine and rodent secretory vesicles. J. Physiol., 542, 453-476.
23. Cousin, M.A. and Robinson, P.J. (2001) The dephosphins: dephosphorylation by calcineurin triggers synaptic vesicle endocytosis. Trends Neurosci., 24, 659-665.
24. Craig, T.J., Evans, G.J. and Morgan, A. (2003) Physiological regulation of Munc18/nSec1 phosphorylation on serine-313. J Neurochem., 86 1450-1457.
25. Fujita, Y., Sasaki, T., Fukui, K., Kotani, H., Kimura, T., Hata, Y., Sudhof, T.C., Scheller, R.H. and Takai, Y. (1996) Phosphorylation of Munc-18/n-Sec1/rbSec1 by protein kinase C: Its implication in regulating the interaction of Munc-18/n-Sec1/rbSec1 with syntaxin. J. Biol. Chem., 271, 7265-7268.
26. Graham, M.E., Fisher, R.J. and Burgoyne, R.D. (2000) Measurement of exocytosis by amperometry in adrenal chromaffin cells: Effects of clostridial neurotoxins and activation of protein kinase C on fusion pore kinetics. Biochimie, 82, 469-479.
27. Chan, S.A. and Smith, C. (2001) Physiological stimuli evoke two forms of endocytosis in bovine chromaffin cells. J. Physiol., 537, 871-885.
28. Nagy, G., Reim, K., Matti, U., Brose, N., Binz, T., Rettig, J., Neher, E. and Sorensen, J.B. (2004) Regulation of releasable vesicle pool sizes by protein kinase A-dependent phosphorylation of SNAP-25. Neuron, 41, 417-429.
29. Chan, B., Greenan, G. McKeon, F. and Ellenberger, T. (2005) Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo. Proc. Natl. Acad. Sci. USA, 102, 13075-13080.
30. Cho, Y.J., Abe, M., Kim, S.Y. and Sato, Y. (2005) Raf-1 is a binding partner of DSCR1. Arch. Biochem. Biophys., 439, 121-128.
31. Porta, S, Serra, S.A., Huch, M., Valverde, M.A., Llorens, F., Estivill, X., Arbonés, M.L. and Martí, E. (2007) RCAN1 (DSCR1) increases neuronal susceptibility to oxidative stress: A potential pathogenic process in neurodegeneration. Hum. Mol. Genet. 16, 1039-1050.